Quantcast
Last updated on April 18, 2014 at 17:22 EDT

Latest GERD Stories

2013-05-21 08:28:59

ORLANDO, Fla., May 21, 2013 /PRNewswire-USNewswire/ -- A study presented at Digestive Disease Week® (DDW) suggests that more objective testing may substantially reduce the cost and risk of managing gastroesophageal reflux disease (GERD). GERD is believed to affect nearly 25 percent of adults. Researchers at New York Presbyterian Hospital and Weill-Cornell Medical College found that almost a third of patients undergoing treatment have no measurable signs of the chronic...

2013-05-20 11:15:26

Studies presented at DDW® 2013 also highlight patient risks There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week® (DDW). A study by New York Presbyterian Hospital and Weill-Cornell Medical College suggests that more objective testing may substantially reduce the cost and risk of managing gastroesophageal reflux disease (GERD). Although...

2013-05-19 08:20:16

Non-Surgical Procedure Yields High Patient Satisfaction Scores; Reduced Need for Medication; No Serious Adverse Effects ORLANDO, Fla., May 19, 2013 /PRNewswire/ -- The non-surgical Stretta® procedure employing low power and low temperature radiofrequency (RF) energy is effective in control of gastroesophageal reflux disease (GERD), and eliminates or reduces the need for medication 10 years post-procedure, according to an independent, prospective long-term assessment presented...

2013-04-01 12:23:41

Calling gastroesophageal reflux a disease increases parents' wish for medication, symptoms are frequently over-treated in infants, according to new research ANN ARBOR, Mich., April 1, 2013 /PRNewswire-USNewswire/ -- Medications used to treat gastroesophageal reflux disease, or GERD, are some of the most widely used medications in children less than one year old. But in a new study, researchers from the University of Michigan and the University of Missouri concluded that physicians...

2013-03-26 20:22:33

WOODCLIFF LAKE, N.J., March 26, 2013 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ACIPHEX(®) Sprinkle(TM) Delayed-Release Capsules 5mg and 10mg for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks. "We are proud to offer a new treatment option for young children who suffer from GERD," said Lonnel Coats, president and CEO of Eisai Inc. "Eisai is committed to keeping the...

2013-03-05 16:24:32

BETHESDA, Md., March 5, 2013 /PRNewswire-USNewswire/ -- New treatment guidelines on the diagnosis and management of gastroesophageal reflux disease (GERD), one of the most prevalent digestive disorders, appear in the March issue of The American Journal of Gastroenterology. The new guidelines from the American College of Gastroenterology provide an overview of GERD and its presentation and offer clinical recommendations for the approach to diagnosis and management of this common condition,...

2013-03-04 08:29:43

GREENWICH, Conn., March 4, 2013 /PRNewswire/ -- The popular and informative MBC health program Green Apples recently aired a health segment on a common condition called Gastroesophageal Reflux Disease, or GERD. In this program, GERD was successfully treated with an innovative therapy called Stretta. Stretta uses a type of energy called radiofrequency, or RF, to remodel the valve at the top of the stomach and restore the ability to keep food contained within the stomach. Stretta is a safe and...

2013-02-21 08:30:44

ST. PAUL, Minn., Feb. 21, 2013 /PRNewswire/ -- For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical's LINX(®) Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process....

2013-02-11 08:26:32

GREENWICH, Conn., Feb. 11, 2013 /PRNewswire/ -- Mederi Therapeutics Inc. today announced that the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) has issued new Clinical Guidelines that strongly recommend Stretta therapy for the treatment of Gastroesophageal Reflux Disease (GERD). The SAGES Clinical Spotlight Review (CSR) process entails an in-depth analysis of the available peer-reviewed clinical evidence, focusing on randomized, controlled...

2013-02-05 20:21:06

Northwestern Medicine experts are the first in Illinois to offer new GERD procedure CHICAGO, Feb. 5, 2013 /PRNewswire-USNewswire/ -- Affecting one in every four Americans, gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disease in the United States. Very little has changed in the treatment of this condition over the last several decades, until now. Last year, a new device to help treat GERD, called the LINX Reflux Management System was approved after four...